06.05.2016 • NewsElaine BurridgeCelluloseAkzoNobel

AkzoNobel and Royal Cosun in Cellulose Pact

AkzoNobel has formed a partnership with agro-industrial cooperative Royal Cosun to develop novel products from cellulose side streams generated from sugar beet processing. The partnership will combine AkzoNobel’s expertise in the chemical modification of cellulose with Royal Cosun’s specialist knowledge in separating and purifying agricultural process side streams.

Geert Hofman, general manager of performance additives at AkzoNobel’s ethylene and sulfur derivatives business, said the collaboration has the potential to deliver a wide range of cellulose-based products which would address the need for more sustainable raw materials from various industries, such as food, healthcare, coatings and construction.

AkzoNobel added that the partnership also underlines its Planet Possible agenda, which includes ongoing efforts to develop and introduce sustainable and bio-based products that contribute to a circular economy. Royal Cosun is comprised of Dutch arable farmers and also includes five business groups – Aviko, Duynie, Sensus, Suiker Unie and SVZ. Its annual turnover is around €2 billion.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.